I think by this point its expected and priced in to some degree, it may cause a little surge in interest like any RNS does but it opens more doors than it adding instant value. So yes I agree with Magsy
Once the first sales RNS lands normally they land more frequently after that, plus eases the pain if we are already moving up when the WHO listing and FDA EU RNS drops
Then believe in your investment, sit on your hands and let nature take its course, at the time of writing this we have just bounced from 8% down to 2%.... welcome to 8am-9am of this share
Agree BB, the mad thing is AVCT just went blue somehow, i feel like when we get some sales news it will put the wind back in our sales for a long rerate